New York, NY -- (SBWIRE) -- 12/07/2013 -- StockMarketIntel.com issues a special report on the following stocks: Senesco Technologies, Inc. (OTCBB:SNTI), Accelerize New Media Inc (OTCBB:ACLZ), Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY), A.P. Pharma, Inc. (OTCBB:APPA)
Senesco Technologies, Inc. (OTCBB:SNTI) gained 6.08% recently, while trading on 15,602 shares, at the price of $5.41. The stock changed hands in a range of $5.16 to $5.41 up till now, bringing its market capitalization at about $16.59 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.90 and was moved to the maximum level of $19.00. Senesco Technologies, Inc. is engaged in utilize its eukaryotic translation initiation Factor 5A, or Factor 5A, and deoxyhypusine synthase (DHS), and related technologies for human therapeutic applications to develop approaches to treat cancer and inflammatory diseases. In agricultural applications, the Company has licensed applications of the Factor 5A, DHS and Lipase platforms to develop the productivity of fruits, flowers, vegetables, agronomic and biofuel feedstock crops through the control of cell death and growth in plants.
Why Should Investors Buy SNTI After The Recent Gain? Just Go Here and Find Out
Accelerize New Media Inc (OTCBB:ACLZ) recently added 3.45%, in the current trading session, at $1.50 with a total volume of 100 shares. The stock, on average, trades on a volume of 13,499 shares. It floated in a range of $1.50 to $1.50 during the recent trading session, with a beta value of 4.61. Its market capitalization now moved to about $86.90 million. In the past 52 weeks, the share price has not declined below $0.41 or above $1.71. Accelerize New Media, Inc. (Accelerize) is a multifaceted online marketing services company specializing in the development of performance-based marketing programs and related software solutions. The Company owns and operates www.cakemarketing.com, an internally-developed Software-as-a-Service (SaaS) platform. Cake Marketing is a hosted software solution that provides an all-inclusive suite of management services for online marketing campaigns. It generates revenues from two sources: SaaS and online marketing services.
What was the Moving Force behind ACLZ on Bullish Run? Read This Research Report
Telecom Corp of New Zealand (ADR) (OTCMKTS:NZTCY) recently added 0.46% and was moving within a range of $9.29-$9.36, its current trading price is $9.36. The stock is moving up till now with a total volume of 19,127 shares, versus an average volume of 73,209 shares. The share price hit its 52-week low of $8.50 and $11.41 was the best price. Telecom Corporation of New Zealand Limited (Telecom) is a supplier of telecommunications and information, communications and technology (ICT) services in New Zealand and Australia. Telecom provides a range of telecommunications and ICT products and services, including local, national, international and telephone services; mobile services, data, broadband and Internet services; information technology (IT) consulting, implementation and procurement, equipment sales, and installation services.
For How Long NZTCY will fight for Profitability? Read This Trend Analysis report
A.P. Pharma, Inc. (OTCBB:APPA) declined -0.89% in its current trading activity, bringing its market capitalization around $205.55 million. The total number of shares that changed hands during the current session up till now was 78,923 shares, as compared to average trading volume of 852,920shares. The share price after opening at $0.46 made a high of $0.46 and hovered above $0.45, while its recent trading price was $0.446. A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery platform. The Company’s lead product candidate, APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) for patients undergoing both moderately and highly emetogenic chemotherapy and for the prevention of delayed CINV for patients undergoing moderately emetogenic chemotherapy.
Will APPA Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)